Catalyst Wire Dossier Catalyst Wire Dossier

IMM-124E (Travelan)

IMM-124E · Immuron Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IMM-124E (Travelan), covering 2026-06-12 to 2026-06-12. Get the full timeline:

Most recent: Clinical Trial Results: Clinical Study to Assess the Efficacy of Once-daily IMM-124E (Travelan®) in a Controlled Human Infection Model. [Phase 2]

See pricing